No abstract available
Keywords:
Cholangiocarcinoma; Cholangiocarcinome; FGFR2 fusion; Fusion FGFR2; IDH mutations; Mutations IDH; NGS; Targeted therapy; Thérapie ciblée.
MeSH terms
-
Bile Duct Neoplasms* / diagnosis
-
Bile Duct Neoplasms* / genetics
-
Bile Duct Neoplasms* / pathology
-
Bile Ducts, Intrahepatic / pathology
-
Cholangiocarcinoma* / diagnosis
-
Cholangiocarcinoma* / genetics
-
Cholangiocarcinoma* / pathology
-
Humans
-
Mutation
-
Signal Transduction